US Broker Ratings

Humana Inc. (HUM) Stock Report: Evaluating Growth Potential with a 6.18% Upside

Humana Inc. (NYSE: HUM) stands as a formidable player in the healthcare sector, focusing on health insurance plans. With a market cap of $33.46 billion, this Louisville, Kentucky-based company has..

Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 15.75% Potential Upside for Investors

Henry Schein, Inc. (NASDAQ: HSIC) remains a formidable player in the healthcare sector, focusing on medical distribution. With its headquarters in Melville, New York, the company has carved out a..

Zoetis Inc. (ZTS) Stock Analysis: Strong Buy Ratings Signal 30% Upside Potential for Investors

Zoetis Inc. (NYSE: ZTS), a heavyweight in the animal health sector, stands out with a substantial market capitalization of $63.86 billion. As a leading provider of animal health medicines, vaccines,..

Avantor, Inc. (AVTR) Stock Analysis: Unveiling a 16.75% Potential Upside Amidst Market Challenges

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing opportunity for investors seeking exposure to a company with significant..

Encompass Health Corporation (EHC) Stock Analysis: 23% Upside Potential and a Strong Buy Consensus

Encompass Health Corporation (NYSE: EHC) stands as a formidable player within the healthcare sector, specializing in post-acute healthcare services. Based in Birmingham, Alabama, the company operates a robust network of..

Neurocrine Biosciences, Inc. (NBIX): Investor Outlook Highlights 22% Potential Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) continues to capture the attention of investors with a promising outlook in the healthcare sector, particularly within the niche of drug manufacturing for specialty and..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Uncovering a 30% Potential Upside Amidst Impressive Revenue Growth

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a biopharmaceutical company with a focus on genetic diseases and cancers, is making waves in the healthcare sector. With a market capitalization of $12.07 billion,..

GSK plc (GSK) Stock Analysis: Navigating Through a Complex Healthcare Landscape

GSK plc (GSK), a stalwart in the healthcare sector, commands a formidable presence in the global drug manufacturing industry. With a robust market capitalization of $94.51 billion, this UK-based company..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth with Strategic Collaborations

For investors with an eye on the healthcare sector, Charles River Laboratories International, Inc. (NYSE: CRL) presents a compelling opportunity. With a market cap of $8.86 billion, CRL operates in..

Quest Diagnostics (DGX) Stock Analysis: A Look at Growth Potential and Analyst Ratings

Quest Diagnostics Incorporated (NYSE: DGX) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a commanding market cap of $19.57 billion, Quest..

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Buy Ratings and Promising 8.6% Upside

Exact Sciences Corporation (NASDAQ: EXAS) stands out in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $12.25 billion, this company has made significant..

Abbott Laboratories (ABT): Investor Outlook with a 16.86% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare industry with a market capitalization of approximately $214.96 billion, continues to be a significant player in the medical devices sector. As..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Biotechnology Powerhouse with 149% Revenue Growth

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands out as a formidable player within the biotechnology sector, emphasized by its impressive market capitalization of $60.25 billion. The company’s strategy centers around the..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 23.28% Potential Upside with Healthcare Innovations

Solventum Corporation (NYSE: SOLV), a rising star in the healthcare sector, is capturing investor attention with its robust portfolio and diverse segment offerings. With a market capitalization of $11.97 billion,..

Waystar Holding Corp. (WAY) Stock Analysis: A Healthcare Tech Powerhouse with 39.64% Upside Potential

Waystar Holding Corp. (NASDAQ: WAY), a leading player in the Health Information Services industry, is making waves in the market with its robust cloud-based software solutions for healthcare payments. Founded..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring a 10% Potential Upside in the Medical Device Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the medical technology industry, presents an intriguing opportunity for investors looking to capitalize on the healthcare sector’s growth. With a market..

Moderna, Inc. (MRNA) Stock Analysis: Unveiling a 48% Upside Potential Amidst Industry Challenges

In the fast-evolving biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) stands as a noteworthy player, particularly recognized for its pioneering messenger RNA (mRNA) medicines. Headquartered in Cambridge, Massachusetts, this U.S.-based company..

Novartis AG (NVS) Stock Analysis: A Healthcare Giant with a 3.23% Dividend Yield and Strong Revenue Growth

Novartis AG (NYSE: NVS), a leading player in the global healthcare sector, has long been a staple for investors seeking exposure to the drug manufacturing industry. Headquartered in Basel, Switzerland,..

Exelixis, Inc. (EXEL) Investor Outlook: A Biotech Powerhouse with a 13.51% Potential Upside

Exelixis, Inc. (NASDAQ: EXEL), a pioneering force in oncology, continues to capture the attention of investors with its focus on developing innovative treatments for challenging cancers. Headquartered in Alameda, California,..

Veeva Systems Inc. (VEEV) Stock Analysis: Unpacking the 10% Potential Upside with Strong Buy Ratings

For investors eyeing the dynamic intersection of technology and healthcare, Veeva Systems Inc. (NYSE: VEEV) presents a compelling opportunity. With a robust market capitalization of $47.73 billion, Veeva Systems stands..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds